Abstract:Human induced pluripotent stem cell (iPSC)-derived neurons have been proposed to be a highly valuable cellular model for studying the pathomechanisms of Alzheimer's disease (AD). Studies employing patient-specific human iPSCs as models of familial and sporadic forms of AD described elevated levels of AD-related amyloid-β (Aβ). However, none of the present AD iPSC studies could recapitulate the synaptotoxic actions of Aβ, which are crucial early events in a cascade that eventually leads to vast brain degeneration. Here we established highly reproducible, human iPSC-derived cortical cultures as a cellular model to study the synaptotoxic effects of Aβ. We developed a highly efficient immunopurification procedure yielding immature neurons that express markers of deep layer cortical pyramidal neurons and GABAergic interneurons. Upon long-term cultivation, purified cells differentiated into mature neurons exhibiting the generation of action potentials and excitatory glutamatergic and inhibitory GABAergic synapses. Most interestingly, these iPSC-derived human neurons were strongly susceptible to the synaptotoxic actions of Aβ. Application of Aβ for 8 days led to a reduction in the overall FM4-64 and vGlut1 staining of vesicles in neurites, indicating a loss of vesicle clusters. A selective analysis of presynaptic vesicle clusters on dendrites did not reveal a significant change, thus suggesting that Aβ impaired axonal vesicle clusters. In addition, electrophysiological patch-clamp recordings of AMPA receptor-mediated miniature EPSCs revealed an Aβ-induced reduction in amplitudes, indicating an impairment of postsynaptic AMPA receptors. A loss of postsynaptic AMPA receptor clusters was confirmed by immunocytochemical stainings for GluA1. Incubation with Aβ for 8 days did not result in a significant loss of neurites or cell death. In summary, we describe a highly reproducible cellular AD model based on human iPSC-derived cortical neurons that enables the mechanistic analysis of Aβ-induced synaptic pathomechanisms and the development of novel therapeutic approaches.

In vivo modeling of human neuron dynamics and Down syndrome

Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons

Realizing the Potential of Exploiting Human IPSCs and Their Derivatives in Research of Down Syndrome

A Single-Cell Model for Synaptic Transmission and Plasticity in Human iPSC-Derived Neurons

Modeling the impact of neuromorphological alterations in Down syndrome on fast neural oscillations

Single-cell RNA Sequencing of Neural Stem Cells Derived from Human Trisomic Ipscs Reveals the Abnormalities During Neural Differentiation of Down Syndrome.

Modeling neurological disorders by human induced pluripotent stem cells

Fully defined NGN2 neuron protocol reveals diverse signatures of neuronal maturation

A human neuronal model of sporadic Alzheimer’s disease induced by downregulation shows Aβ aggregation, tau hyperphosphorylation and functional network impairment

A quantitative framework to evaluate modeling of cortical development by neural stem cells.

Modeling Alzheimer’s disease with iPSC-derived brain cells

Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation

Species-specific maturation profiles of human, chimpanzee and bonobo neural cells

An in vivo and in vitro spatiotemporal atlas of human midbrain development

SYNGAP1 deficiency disrupts synaptic neoteny in xenotransplanted human cortical neurons in vivo

Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects

Deficits in Human Trisomy 21 Ipscs and Neurons

Modeling neurological diseases using iPSC-derived neural cells

A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction

Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons

Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma